As of 19 February 2024
(Shareholdership in accordance with transparency declarations received by the company and notified managers’ transactions)
1 François Fornieri holds warrants entitling him to subscribe 200,000 additional shares of Mithra through Yima SRL, a company fully owned by François Fornieri.
2 François Fornieri, Alychlo NV and Noshaq SA jointly hold 300,000 warrants (share lending warrants).
As of 19 December 2023
all relating to ordinary shares
all ordinary shares
all related to the LDA warants issued on 22 July 2020 and to be exercised progressively pursuant to the warrant plan
all related to the share lending warrants issued on 7 September 2020 and to be exercised progressively pursuant to the warrant plan
all related to the warrants issued on 20 November 2020 and potentially exercised upon grant
all related to the Investment Options issued on 23 November 2023 and to be exercised as from the Listing Prospectus Approval 2023
all related to warrants issued on 23 November 2023 and to be exercised as from the Listing Prospectus Approval 2023
all related to warrants issued on 19 December 2023
Get the latest news: subscribe to our Newsletter!
Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming women’s health by offering new choices through innovation, with a particular focus on contraception and menopause.
Mithra (Headquarter)
Rue Saint-Georges 5
4000 Liège
Belgium
+32 (0)4 349 28 22
info@mithra.com
Mithra CDMO
Rue de l’Expansion 57
4400 Flémalle
Belgium
+32 (0)4 353 37 00
info@mithracdmo.com